OriGene Technologies, Inc.(製薬・医療分野):企業M&A動向

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDPH195017D)
◆英語タイトル:OriGene Technologies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆発行会社/調査会社:GlobalData
◆商品コード:GDPH195017D
◆発行日:2014年4月25日
◆調査対象地域:アメリカ
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[OriGene Technologies, Inc.(製薬・医療分野):企業M&A動向]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Summary

OriGene Technologies, Inc. (OriGene) is a gene centric life sciences company. The company undertakes the development, manufacture and selling of genome wide research and diagnostic products worldwide. Its products include cDNA clones, HuSH shRNA, siRNA miRNA, qPCR Reagents, Plasmid Purification, Transfection Reagent, PrecisionShuttling kits, proteins antibodies, IHC products, assays, human tissues and among others. The company provides services such as include gene synthesis, custom cloning, custom shRNA, custom protein service, antibody service, assay development and stable cell line development. OriGene’s research areas include cancer biomarker research, RNAi, pathology IHC, stem cell research, ion channels, and protein kinase. The company also provides exclusive gene expression products including TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation. It distributes its products in Asia, Europe and North American countries. OriGene is headquartered in Rockville, Maryland, the US.

OriGene Technologies, Inc. – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
OriGene Technologies, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 5
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 7
OriGene Technologies, Inc., Medical Devices Deals, 2008 to YTD 2014 8
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 11
Venture Financing 13
OriGene Technologies Raises US$21 Million In Series C Financing 13
Origene Technologies Raises US$15 Million In Venture Financing 15
OriGene Technologies Raises US$16 Million In Series B Financing Round 16
OriGene Secures Additional US$6.5 Million In Equity Financing 18
Partnerships 19
Strategic Diagnostics Enters Into Co-Development Agreement With Banyan Biomarkers 19
OriGene Technologies Enters Co-Development Agreement With The Institute For Systems 20
Novus Biologicals Enters Into Co-Development Agreement With Strategic Diagnostics 21
Essen Instruments Enters Into Co-Development Agreement With OriGene Technologies 22
Strategic Diagnostics Enters Into Collaboration With Fred Hutchinson Cancer Research 23
Asset Transactions 24
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 24
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 26
Acquisition 28
OriGene Technologies Acquires Blue Heron Biotech 28
OriGene Technologies Acquires Marligen Biosciences 30
OriGene Acquires Shenzhen 31
OriGene Technologies, Inc. – Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Key Facts 1
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 1
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 1
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 1
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
OriGene Technologies, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 5
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
OriGene Technologies, Inc., Deals By Therapy Area, 2008 to YTD 2014 7
OriGene Technologies, Inc., Medical Devices Deals, 2008 to YTD 2014 8
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 11
OriGene Technologies Raises US$21 Million In Series C Financing 13
Origene Technologies Raises US$15 Million In Venture Financing 15
OriGene Technologies Raises US$16 Million In Series B Financing Round 16
OriGene Secures Additional US$6.5 Million In Equity Financing 18
Strategic Diagnostics Enters Into Co-Development Agreement With Banyan Biomarkers 19
OriGene Technologies Enters Co-Development Agreement With The Institute For Systems 20
Novus Biologicals Enters Into Co-Development Agreement With Strategic Diagnostics 21
Essen Instruments Enters Into Co-Development Agreement With OriGene Technologies 22
Strategic Diagnostics Enters Into Collaboration With Fred Hutchinson Cancer Research 23
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 24
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 26
OriGene Technologies Acquires Blue Heron Biotech 28
OriGene Technologies Acquires Marligen Biosciences 30
OriGene Acquires Shenzhen 31
OriGene Technologies, Inc., Key Competitors 32
OriGene Technologies, Inc., Key Employees 33
OriGene Technologies, Inc., Other Locations 34
OriGene Technologies, Inc., Subsidiaries 34

List of Figures
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 1
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 5
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
OriGene Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 7
OriGene Technologies, Inc., Medical Devices Deals, 2008 to YTD 2014 8

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国のネナシカズラ種子エキス市場2017
    The 'Global and Chinese Dodder Seed Extract Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Dodder Seed Extract industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dodder Seed …
  • 世界の気相エアフィルタ市場2016
    Notes:Production, means the output of Gas-phase Air Filters Revenue, means the sales value of Gas-phase Air Filters This report studies Gas-phase Air Filters in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, …
  • 樹脂製レンズの世界及び中国市場 2018年
    The 'Global and Chinese Resin Lenses Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Resin Lenses industry with a focus on the Chinese market. The report provides key statistics on the market status of the Resin Lenses manufacturers …
  • IFM Efector Pty Ltd – 企業概要
    WMI's 'IFM Efector Pty Ltd - Company Capsule' is a crucial resource for industry executives and anyone looking to access key information about 'IFM Efector Pty Ltd'. WMI's 'IFM Efector Pty Ltd - Company Capsule' report utilizes a wide range of primary and secondary sources, which are analyzed and pr …
  • 世界のオイル吸着剤市場2017
    Oil Adsorbent Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, G …
  • テロドリンの世界市場2019
    The Global Telodrin (CAS 297-78-9) Industry 2019 Market Research Report is a professional and in-depth study on the current state of the Telodrin industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. …
  • カナダのアンチモン市場2016-2020
    About The report brings together facts and figures about antimony market in Canada covering period of 2010-2020. Statistics, experts’ opinions and estimations are given. The report about antimony market in Canada covers: - reserves, mines, production - manufacturers - demand structure, trends - cons …
  • Energinet.dk(代替エネルギー分野):企業のM&A・提携動向
    Summary Energinet.dk (Energinet) is a state-owned company represented by the Danish Ministry of Climate, Energy and Building. It engages in the ownership, operation, and maintenance of transmission systems for electricity and natural gas in Denmark. The company develops electricity and gas transmiss …
  • 女性用除毛製品の世界市場:除毛クリーム、カミソリ、除毛器
    About Female Depilatory Products Market The global female depilatory products market is driven by the established nature of organized retail in the developed markets and product innovation. Product innovation requires significant investment in R&D. L’Oréal invested $847 million in the R&D of its cos …
  • ロシアの合成工業用ダイアモンド市場2016-2020
    About The report brings together facts and figures about synthetic industrial diamonds market in Russia covering period of 2010-2020. Statistics, experts’ opinions and estimations are given. The report about synthetic industrial diamonds market in Russia covers: - reserves, mines, production - manuf …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDPH195017D )"OriGene Technologies, Inc.(製薬・医療分野):企業M&A動向" (英文:OriGene Technologies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。